Ls174t cells cl 188

Manufactured by American Type Culture Collection

Sourced in United States

LS174T cells (CL-188) are a human colon adenocarcinoma cell line. The cells express the carcinoembryonic antigen (CEA) and can be used for research purposes.

Automatically generated - may contain errors

Lab products found in correlation

Mcf 7 htb 22 cells, by American Type Culture Collection (1 mentions)

2 protocols using ls174t cells cl 188

LS174T Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols

LS174T cells (CL-188)
were obtained from American Type Culture Collection (ATCC, Manassas,
VA, USA). The cells were cultured in EMEM supplemented with 10% FBS,
100 U/mL penicillin, and 100 ng/mL streptomycin. The cells were incubated
at 37 °C in a humidified atmosphere with 5% CO₂ and
95% air.

Nabekura T., Kawasaki T., Furuta M., Kaneko T, & Uwai Y. (2018). Effects of Natural Polyphenols on the Expression of Drug Efflux Transporter P-Glycoprotein in Human Intestinal Cells. ACS Omega, 3(2), 1621-1626.

+ Open protocol

+ Expand

Culturing LS174T and MCF7 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols

Human intestinal epithelial LS174T cells (CL-188) and human breast cancer MCF7 cells (HTB-22) were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). The cells were cultured in EMEM supplemented with 10% FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin. The cells were then incubated at 37 °C in a humidified atmosphere with 5% CO₂ and 95% air.

Nabekura T., Kawasaki T., Jimura M., Mizuno K, & Uwai Y. (2020). Microtubule-targeting anticancer drug eribulin induces drug efflux transporter P-glycoprotein. Biochemistry and Biophysics Reports, 21, 100727.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!